LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $10,049,000 | +0.6% | 73,386 | 0.0% | 0.09% | +7.4% |
Q3 2017 | $9,992,000 | +12.2% | 73,386 | 0.0% | 0.08% | +3.8% |
Q2 2017 | $8,909,000 | +14.7% | 73,386 | 0.0% | 0.08% | +21.9% |
Q1 2017 | $7,767,000 | +4.2% | 73,386 | 0.0% | 0.06% | -12.3% |
Q4 2016 | $7,457,000 | -0.4% | 73,386 | 0.0% | 0.07% | +7.4% |
Q3 2016 | $7,490,000 | -14.4% | 73,386 | 0.0% | 0.07% | -26.1% |
Q2 2016 | $8,753,000 | +11.4% | 73,386 | 0.0% | 0.09% | +10.8% |
Q1 2016 | $7,859,000 | -1.2% | 73,386 | 0.0% | 0.08% | +25.8% |
Q4 2015 | $7,957,000 | +26.6% | 73,386 | 0.0% | 0.07% | +13.8% |
Q3 2015 | $6,286,000 | -15.1% | 73,386 | 0.0% | 0.06% | -10.8% |
Q2 2015 | $7,405,000 | +30.9% | 73,386 | 0.0% | 0.06% | +38.3% |
Q1 2015 | $5,659,000 | +44.9% | 73,386 | -0.0% | 0.05% | +17.5% |
Q4 2014 | $3,906,000 | +13.3% | 73,400 | 0.0% | 0.04% | -7.0% |
Q3 2014 | $3,449,000 | -24.6% | 73,400 | 0.0% | 0.04% | -23.2% |
Q2 2014 | $4,572,000 | -7.4% | 73,400 | 0.0% | 0.06% | -11.1% |
Q1 2014 | $4,937,000 | – | 73,400 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |